retatrutide clinical trial south korea Incretin-based therapies for the treatment of obesity-related diseases Retatrutide Where to Get: Can

The Phase 3 SYNCHRONIZE trials use extended, flexible dose escalation, which is expected to substantially improve tolerability

Tirzepatide sublingual drops Tirzepatide drops represent the dual-agonist approach, targeting both GLP-1 and GIP receptors simultaneously

These findings provide a clear foundation for clinical decision-making in severe obesity management

7 Pharmacists should be diligent in staying up to date with emerging benefits of GLP-1 RAs, especially in new indications such as PD, and follow releases of new clinical data that more confidently highlight the role of GLP-1 RAs in PD

Trial eligibility: what criteria would a study require